← Leaderboards
Karen J Wernli
Kaiser Foundation Health Plan Of Washington
$11,067,858
Attributed
$12,190,635
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$6,110,713 · 1
NIH$6,079,922 · 5
By mechanism
U01$6,110,713 · 1
R01$3,340,674 · 1
UG3$1,684,165 · 1
U54$494,041 · 1
R21$401,042 · 1
R03$160,000 · 1
Top collaborators
- Anne Laure Escaron1 shared
- Matthew Adam Triplette1 shared
Most similar at Kaiser Foundation Health Plan Of Washington
Same institution · by research overlap
- Beverly Beth Green$11,906,070
- Jessica Chubak$9,869,663
- Aruna Kamineni$6,497,350
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultCessation Of LifeMemberMedicalScreening For CancerGuidelinesCompare EffectivenessScreeningWashingtonColorectal CancerMorbidity - Disease RateRecommendationFollow-UpReportingCaringMalignant NeoplasmsHigh RiskBaseRandomizedClinical TrialsModificationLung Cancer ScreeningLungMalignant Breast Neoplasm
Grant awards (19)
Expanding Lung Cancer Screening to Achieve Excellence (EXHALE)$1,684,165
UG3 · FY2025 · CA · contact PI
RFA-IP-22-004, Evaluating influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness in prevention of acute illness in Washington state 2022-2027$1,310,713
U01 · FY2025 · IP · contact PI
Multilevel Interventions to Increase Adherence to Lung Cancer Screening$621,529
R01 · FY2025 · CA · contact PI
RFA-IP-22-004, Evaluating influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness in prevention of acute illness in Washington state 2022-2027$1,400,000
U01 · FY2024 · IP · contact PI
Multilevel Interventions to Increase Adherence to Lung Cancer Screening$606,211
R01 · FY2024 · CA · contact PI
RFA-IP-22-004, Evaluating influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness in prevention of acute illness in Washington state 2022-2027$1,400,000
U01 · FY2023 · IP · contact PI
Multilevel Interventions to Increase Adherence to Lung Cancer Screening$641,003
R01 · FY2023 · CA · contact PI
Patient Provider Communication Larch Supplement$99,999
R01 · FY2023 · CA · contact PI
Evaluating influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness in prevention of acute illness in Washington state 2022-2027$2,000,000
U01 · FY2022 · IP · contact PI
Multilevel Interventions to Increase Adherence to Lung Cancer Screening$659,732
R01 · FY2022 · CA · contact PI
Multilevel Interventions to Increase Adherence to Lung Cancer Screening$712,200
R01 · FY2021 · CA · contact PI
National trends in end of life care for adolescent and young adult cancer patients$144,804
R21 · FY2017 · CA · contact PI
National trends in end of life care for adolescent and young adult cancer patients$256,238
R21 · FY2016 · CA · contact PI
Comparative effectiveness of colorectal cancer screening$153,758
U54 · FY2015 · CA · contact PI
Comparative effectiveness of colorectal cancer screening$149,494
U54 · FY2014 · CA · contact PI
Comparative effectiveness of colorectal cancer screening$127,432
U54 · FY2013 · CA · contact PI
Mammographic Breast Density and Ovarian Cancer$80,000
R03 · FY2012 · CA · contact PI
Comparative effectiveness of colorectal cancer screening$63,357
U54 · FY2012 · CA · contact PI
Mammographic Breast Density and Ovarian Cancer$80,000
R03 · FY2011 · CA · contact PI